Sansure Biotech Inc. Class ASSE: 688289

Announcement on Vesting Results for the 1st Vesting Period of the Initial Granted Part under the 2023 Phase II Restricted Stock Incentive Plan

· Issued by Sansure Biotech Inc. Class A via Shanghai Stock Exchange
Announcement on Vesting Results for the 1st Vesting Period of the Initial Granted Part under the 2023 Phase II Restricted Stock Incentive Plan

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis